TNNI3 and hydrops fetalis: Hence, several cardiac biomarkers have been researched through the years for early screening of these diseases, including cardiac troponin I (cTnI), an indicator of AMI, and Human N-terminal pro-B-type natriuretic peptide (NT-proBNP), an HF biomarker.